Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Current Leases (2019 - 2025)

China Pharma Holdings (CPHI) has disclosed Current Leases for 7 consecutive years, with $70326.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Leases rose 16.74% year-over-year to $70326.0, compared with a TTM value of $70326.0 through Sep 2025, up 16.74%, and an annual FY2024 reading of $39323.0, down 49.41% over the prior year.
  • Current Leases was $70326.0 for Q3 2025 at China Pharma Holdings, up from $19776.0 in the prior quarter.
  • Across five years, Current Leases topped out at $86672.0 in Q1 2022 and bottomed at $19776.0 in Q1 2025.
  • Average Current Leases over 5 years is $63533.0, with a median of $75425.0 recorded in 2023.
  • The sharpest move saw Current Leases plummeted 76.21% in 2023, then surged 279.71% in 2024.
  • Year by year, Current Leases stood at $85282.0 in 2021, then crashed by 52.57% to $40445.0 in 2022, then soared by 92.18% to $77727.0 in 2023, then crashed by 49.41% to $39323.0 in 2024, then soared by 78.84% to $70326.0 in 2025.
  • Business Quant data shows Current Leases for CPHI at $70326.0 in Q3 2025, $19776.0 in Q1 2025, and $39323.0 in Q4 2024.